Abstract: Notch signaling is involved in osteogenic differentiation; however, its role differs depending on cell type and differentiation stage. Here, we investigated the involvement of Notch signaling in the osteogenic differentiation of retinoic acid-treated embryoid bodies derived from mouse gingival fibroblast-derived induced pluripotent stem cells (mGF-iPSCs). When cultured in osteogenic media, mGF-iPSCs showed an increase in their expression of osteogenic marker genes and deposited a mineralized matrix. Furthermore, increased levels of mRNA for Notch1, Notch2, and Hey1 were observed. In the presence of DAPT, a Notch signaling inhibitor, during osteogenic induction, mRNA levels for osteogenic marker genes were significantly decreased; however, no difference was noted in mineral deposition. Moreover, activation of Notch signaling using Jagged1-immobilized surfaces resulted in a slight increase of in vitro mineralization on days 3 and 7 of osteogenic induction. Significant upregulation of Dlx5, Bsp, and Col I mRNA expression was observed in mGF-iPSCs cultured on Jagged1 surfaces. In conclusion, inhibition and activation of Notch signaling was shown to decrease and increase mGF-iPSC osteogenic differentiation, respectively. However, the responses were not robust, suggesting the involvement of additional signaling pathways.
Introduction
Reprogramming of mature cells by transfecting them with factors regulating their pluripotency is considered a potentially useful approach for obtaining stem cells because it overcomes ethical concerns about the use of embryonic stem cells. Recently, mouse gingival fibroblast-derived induced pluripotent stem cells (mGF-iPSCs) were successfully generated with higher reprogramming efficiency in comparison with dermal fibroblasts (1) . Murine induced pluripotent stem cells (miPSCs) are currently considered an attractive cell type for osteogenic differentiation (2) . For the efficient osteogenic differentiation of mGF-iPSCs, all-trans retinoic acid (RA)-treated embryoid bodies, which contain immature mesenchymal cells, are used (3, 4) . Osteogenic induction markedly promotes osteoblastrelated gene expression and mineral deposition by these cells. However, it should be noted that the osteogenesisrelated genes expressed by mGF-iPSCs differ from those expressed by mesenchymal stem cells (MSCs), implying that different regulatory mechanisms are involved (4) . mGF-iPSCs may be an excellent cell source for bone regeneration treatments. However, before iPSCs can be applied clinically, their mechanisms of differentiation Journal of Oral Science, Vol. 59, No. 3, [405] [406] [407] [408] [409] [410] [411] [412] [413] 2017 Original Notch signaling partly regulates the osteogenic differentiation of retinoic acid-treated murine induced pluripotent stem cells Thanaphum Osathanon 1) , Jeeranan Manokawinchoke 1) , Hiroshi Egusa 2) , and Prasit Pavasant 1) must be clarified in order to ensure that their complete differentiation results in bone regeneration, without the development of teratomas. Notch signaling regulates several differentiation processes (5) (6) (7) (8) (9) , including bone healing. Increased expression of various Notch signaling components has been observed in healing tibial and calvarial fractures (10) . Moreover, mice with genetically impaired Notch signaling have been reported to exhibit decreased bone healing and remodeling (11) . The Notch ligand Jagged1 plays a crucial role in bone healing, as demonstrated by its upregulation during the healing process (10) . However, the role of Notch signaling in osteogenic differentiation is still unresolved. Notch signaling activation promotes osteogenic differentiation of human MSC (6, 12) . In contrast, an inhibitory effect of Notch signaling in osteogenic differentiation has been noted in several cell types (5, 13) , leading to the hypothesis that the regulation of osteogenic differentiation by Notch signaling may be cell type-and stage-specific. However, the function of Notch signaling in iPSC osteogenic differentiation is unknown. Therefore, the aim of the present study was to investigate the involvement of Notch signaling in the osteogenic differentiation of retinoic acid-treated embryoid bodies derived from mGF-iPSCs.
Materials and Methods
Cell culture mGF-iPSCs, which had been previously generated using retroviral introduction of Oct3/4, Sox2, and Klf4 (1), were used in this study. mGF-iPSCs were cultured on SNL feeder cells in ES medium containing Dulbecco's Modified Eagle Medium (DMEM; Nacalai Tesque, Kyoto, Japan), 15% fetal bovine serum (FBS; Gibco BRL, Carlsbad, CA, USA), 2 mM L-glutamine, 0.1 mM non-essential amino acids, 0.1 mM 2-mercaptoethanol, 50 U of penicillin, and 50 μg/mL streptomycin (1).
Osteogenic induction
Embryoid bodies were obtained by trypsinizing the mGF-iPSCs and seeding them on low-attachment culture dishes in ES medium. The embryoid bodies were maintained in ES medium for 2 days, and further maintained in ES medium supplemented with RA (Sigma-Aldrich, St. Louis, MO, USA; 1 μM) for another 2 days to induce mesenchymal lineage commitment. Aliquots of the embryoid body cultures were incubated with trypsin to obtain single-cell suspensions. The cells in suspension were then counted and used for seeding density calculations. The suspended embryoid bodies were seeded (250,000 cell/cm 3 ) on 0.1% gelatin-coated tissue culture plates and allowed to attach in RA-supplemented ES medium for 24 h. In the Notch induction experiments, the suspended cells were seeded on Jagged1-immobilized surfaces and maintained in RA-supplemented ES medium for 24 h. Subsequently, the culture medium was changed to osteogenic medium. The control cultures were maintained in growth medium consisting of DMEM (Gibco BRL) supplemented with 100 unit/mL penicillin (Gibco BRL), 100 μg/mL streptomycin (Gibco BRL), 250 ng/mL amphotericin B (Gibco BRL), 2 mM L-glutamine (1× Glutamax) (Gibco BRL), and 15% FBS (Gibco BRL). For osteogenic induction, the growth medium also contained 50 μg/mL ascorbic acid (SigmaAldrich), 100 nM dexamethasone (Sigma-Aldrich), and 10 mM β-glycerophosphate (Sigma-Aldrich). For the Notch inhibition experiments, cells were treated with a γ-secretase inhibitor (DAPT; Sigma-Aldrich) and the vehicle solution was added to the control medium.
Jagged1 immobilization
Jagged1 immobilization was performed as described previously (12) . Briefly, the tissue culture plates were incubated with 50 μg/mL recombinant protein G (Invitrogen, Carlsbad, CA, USA) solution for 16 h and then with 10 mg/mL bovine serum albumin (Sigma-Aldrich) for 2 h. Recombinant human Jagged1/Fc (R&D Systems, Minneapolis, MN, USA) was subsequently incubated on the plate surface for 2 h. Human IgG Fc fragment was used as a control. The surfaces were rinsed with sterile PBS between each step.
Alizarin red staining
Cells were fixed with cold methanol for 10 min and rinsed with deionized water. Calcium deposits were stained using 1% Alizarin Red S solution (Sigma-Aldrich) at room temperature. For quantification of mineral deposition, the stained alizarin red dye was solubilized in 10% cetylpyridinium chloride monohydrate solution. The supernatant was collected and measured at an absorbance of 570 nm.
Polymerase chain reaction
Total RNA was extracted using Isol-RNA Lysis Reagent (5 PRIME, Gaitherburg, MD, USA). The cDNA was generated using an avian myeloblastosis virus reverse transcriptase enzyme (Promega, Madison, WI, USA) for 90 min at 42°C. The real-time polymerase chain reaction was performed using FastStart Essential DNA Green Master (Roche Applied Science, Indianapolis, IN, USA) in a Lightcycler Nano real-time PCR system (Roche Applied Science). FastStart Essential DNA Green Master is a hot start polymerase chain reaction mix containing Taq DNA polymerase, reaction buffer, dNTP mix, SYBR Green I dye, and MgCl 2 . The polymerase chain reaction began with denaturing at 95°C for 1 min followed by 40 amplification cycles consisting of denaturing at 95°C for 10 s, annealing at 60°C for 10 s, and extension at 72°C for 25 s, followed by a final extension step at 72°C for 20 min. Post-amplification melting curve analysis was performed to confirm product specificity. The expression levels were normalized to the expression of 18S ribosomal RNA and the control conditions. The semiquantitative polymerase chain reaction was performed using Taq DNA polymerase (Roche Applied Science) in a thermocycling machine. The semi-quantitative polymerase chain reaction was performed starting with a denaturation cycle at 94°C for 1 min. Thirty amplification cycles were then performed, starting with denaturation at 94°C for 45 s, primer annealing at 60°C for 60 s, and chain elongation at 72°C for 90 s. The final step was an extension cycle at 72°C for 10 min. The products were electrophoresed in a 1.8% agarose gel and stained with ethidium bromide. The primer sequences are shown in Table 1 (4, (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) Statistical analysis Data are shown as mean ± standard deviation. Statistical analysis was performed using the two-independent samples t-test for two-group comparisons and one-way 
ANOVA follow by Dunnett's post hoc test for comparisons of three or more groups. Statistical significance was considered at P < 0.05.
Results

mGF-iPSC osteogenic differentiation
Osteogenic induction of mGF-iPSCs was performed as described previously (Fig. 1A) (4) . Osteogenic marker gene upregulation was observed after culturing RA-treated embryoid bodies in osteogenic medium (Fig. 1B-H) . A significant increase in Runx2 and Col I expression was seen at day 7, while expression of Osx and Dmp1 mRNA was significantly upregulated at day 21. Furthermore, significant upregulation of Bmp2 and Ocn mRNA was noted. In addition, mineral deposition increased in a time-dependent manner (Fig. 1I) . Together, these results demonstrated that mGF-iPSCs underwent osteogenic differentiation.
RA-treated embryoid bodies expressed Notch receptors (Notch1, Notch2, Notch3, and Notch4) and Notch target genes (Hes1 and Hey1) (Fig. 2A) . During osteogenic differentiation, significant upregulation of Hey1 expression was seen on days 3, 7, 14, and 21 (Fig. 2C) . Moreover, significant increases in Notch1 and Notch2 mRNA levels were observed. Notch2 mRNA levels were upregulated on days 3 and 7, and Notch1 mRNA levels were significantly increased on day 21 ( Fig. 2D-E) . No significant change in Notch3 and Notch4 mRNA expression was found (data not shown).
Jagged1 immobilization-enhanced osteogenic marker gene expression in RA-treated embryoid bodies when cultured in growth medium
To determine the role of Notch signaling in osteogenic marker gene expression, RA-treated embryoid bodies were seeded on 10 nM Jagged1-immobilized surfaces to activate Notch signaling when cultured in normal growth medium. Significant upregulation of Hes1, Hey1, and HeyL mRNA expression was noted in the Jagged1-treated group on day 3 ( Fig. 3A-D) . Moreover, a trend for upregulated expression of osteogenic marker genes was evident in the Jagged1-treated group (Fig. 3E-K) . A significant increase in Dlx5, Bsp, and Col 1 mRNA expression was demonstrated in the Jagged1-treated group on day 3. In addition, the expression of HeyL, a Notch target gene, and Dlx5 and Bsp, osteogenic marker genes, was increased in a dose-dependent manner after the cells had been seeded on Jagged1-immobilized surfaces (Fig. 4) .
Jagged1 immobilization slightly enhances mineral deposition when RA-treated embryoid bodies are cultured in osteogenic medium
RA-treated embryoid bodies were seeded on Jagged1-immobilized surfaces and maintained in osteogenic medium. Of the Notch target genes evaluated, upregulation of Hey1 and HeyL was observed in the Jagged1-treated group on day 3 ( Fig. 5A-D) . However, no significant difference in expression was noted on day 7. Furthermore, no significant differences in osteogenic marker gene expression were detected (Fig. 5E-K) . However, a significant difference in Col 1 mRNA expression was detected in the immobilized Jagged1 group on day 3. A slight increase in mineral deposition by the cells seeded on Jagged1-immobilized surfaces was evident on days 3 and 7 (Fig. 5L) . A γ-secretase inhibitor attenuates osteogenic marker gene expression when RA-treated embryoid bodies are cultured in osteogenic medium Intracellular Notch signaling was inhibited using DAPT (a γ-secretase inhibitor), which prevents intracellular Notch receptor cleavage. RA-treated embryoid bodies were seeded on gelatin-coated dishes and maintained in osteogenic medium supplemented with 10 or 20 μM DAPT. A significant decrease of Notch target gene (Hes1, Hey1, Hes5, and HeyL) expression was observed on day 3, indicating that intracellular Notch signaling was partially inhibited (Fig. 6A-D) . The expression of Hes1 and HeyL mRNA was also significantly reduced on day 7. Correspondingly, expression of osteogenic marker genes was significantly decreased on day 3 in the DAPTtreated groups (Fig. 6E-K) . However, only Runx2, Bsp, and Bmp2 mRNA expression was significantly different on day 7 in comparison with the control. However, no Fig. 5 Effect of Notch signaling activation on mGF-iPSC osteogenic differentiation. Cells were seeded on Jagged1-immobilized surfaces and maintained in osteogenic medium. The mRNA levels of Notch target genes (A-D) and osteogenic marker genes (E-K) were evaluated using real-time polymerase chain reaction on days 3 and 7. Mineral deposition was determined using Alizarin Red S staining on days 3 and 7 (L). Asterisks indicate a significant difference compared with the control.
Fig. 6
Effect of Notch signaling inhibition on osteogenic differentiation of mGF-iPSCs. RA-treated embryoid bodies were seeded on gelatin-coated dishes and maintained in osteogenic medium supplemented with γ-secretase inhibitor (DAPT). In controls, the DMSO vehicle was added. The mRNA levels of Notch target genes (A-D) and osteogenic marker genes (E-K) were evaluated using real-time polymerase chain reaction on days 3 and 7 of osteogenic induction. Mineral deposition was determined using Alizarin Red S staining at 10 days of osteogenic differentiation (L). Asterisks indicate a significant difference compared with the control. change in mineral deposition was noted.
Discussion
Previous studies have demonstrated the osteogenic potential of iPSCs (4, 29) . Although successful bone healing/ regeneration occurred when using these cells, teratoma formation was observed in 20% of the mice with transplanted osteogenically-induced iPSCs (30) . These results suggest that differentiation of cells may be incomplete and that undifferentiated cells persist after osteogenic induction. Therefore, research focusing on enhancement of iPSC osteogenic differentiation is necessary.
Notch activation can either positively or negatively regulate osteogenic differentiation, depending on various experimental parameters (e.g., cell type, differentiation stage, and activation methods) (6, 12, 13, 31) . Notch receptor and ligand upregulation has been observed during bone fracture healing (10) . In addition, Notch inhibition results in a smaller callus size and a decreased osteogenic cell population (11) . However, it has also been demonstrated that Notch signaling promotes the proliferation of immature osteogenic cells and stimulates the expression of Osx, Alp, and Bsp, whereas osteoblast maturation is inhibited by direct binding to Runx2 (32) .
In the present study, Hey1 mRNA expression was significantly upregulated when RA-treated embryoid bodies were cultured on gelatin-coated plates in osteogenic medium. Correspondingly, a previous study demonstrated that Hey1 participated in the osteogenic differentiation of MSCs. Hey1 deficiency resulted in a reduction of BMP-9-induced alkaline phosphatase enzymatic activity and Runx2 expression, and Hey1 knockdown resulted in a decrease of BMP-9-induced osteogenic differentiation both in vitro and in vivo (33) . In addition, BMP-7 and BMP-2 have been reported to induce Hey1 expression in human and mouse MSCs (34, 35) . Furthermore, mineral deposition was completely inhibited in HEY1-knockdown human MSCs (35) . However, other studies demonstrated that HEY1 did not influence osteogenic differentiation (22, 36) . In view of these conflicting findings, the specific function of Hey1 in mGF-iPSCs requires further investigation. In the present study, we observed increased levels of Notch1 and Notch2 mRNA during mGF-iPSC osteogenic differentiation. This observation concurs with that of a previous study demonstrating a correlation between upregulated expression of Notch receptor mRNA with upregulation of mRNA for osteogenic markers in primary alveolar bone-derived progenitor cells (37) . Together, these results suggest the participation of Notch signaling in mGF-iPSC osteogenic differentiation.
DAPT, a γ-secretase inhibitor, was used to determine whether endogenous Notch signaling is required for mGF-iPSC osteogenic differentiation. The mRNA levels of osteoblast markers we evaluated were decreased on day 3 in the presence of DAPT. However, for some markers, the inhibitory effects of DAPT were attenuated on day 7, corresponding to the lack of any difference in mineralization. This suggests that additional signaling pathways, along with Notch signaling, regulate mGF-iPSC osteogenic differentiation, and therefore that Notch signaling may be dispensable for this process. Correspondingly, DAPT treatment of human MSCs did not alter their alkaline phosphatase activity and mineralization relative to control cells (38) . In contrast, DAPT-treated rat periodontal ligament stem cells exhibited a decrease of mineral deposition when cultured in osteogenic medium (39) . Thus, the regulation of osteogenic differentiation by Notch signaling may be cell type-specific.
One limitation of the present study was the timing of Notch signaling activation. The immobilized Jagged1 surfaces activated Notch signaling immediately upon culture, which may not be an appropriate time frame for effective induction of osteogenic differentiation. This may explain the non-robust osteogenic response of mGF-iPSCs observed in the present study. As mentioned previously, Notch signaling activation at different stages of differentiation results in different cell responses. Jagged1-immobilized surfaces have been reported to enhance ectodermal differentiation of undifferentiated human embryonic stem cells and to promote cardiomyocyte differentiation of human embryonic stem cell-derived cardiovascular progenitor cells (40) . It has also been demonstrated that Jagged1 inhibits the expression of osteogenic marker genes in mouse bone marrow-derived MSCs (41) . These results suggest that the role of Notch signaling in osteoblast differentiation may be cell stage-specific. Jagged1-immobilized fibrin microparticles have been developed to control the timing of Notch signaling activation (40) . Using these Notchactivating microparticles, time-specific activation of Notch signaling may be achieved, thus controlling intracellular signaling more precisely. Further investigation will be needed to determine whether a Notch signalingspecific activation period can enhance the osteogenic differentiation of RA-treated mGF-iPSCs.
It should also be noted that the present study focused mainly on the influence of Notch signaling on gene expression in mGF-iPSCs. PCR is a common procedure for determining changes in gene expression. However, changes in gene expression may not result in commensurate changes in protein expression levels. Therefore, we used mineral deposition to evaluate changes in cell function after inhibition or activation of Notch signaling in mGF-iPSCs. Our results showed that mineral deposition changed slightly after manipulation of Notch signaling. Thus, changes in mRNA levels should be interpreted with caution because they may not correlate with changes in protein expression or cell function.
The results of the present study imply that inhibition and activation of Notch signaling alter the osteogenic differentiation of RA-treated embryoid bodies derived from mGF-iPSCs. However, the responses we observed were not robust. As reported previously, Jagged1 markedly enhanced the expression of osteogenic marker genes and mineral deposition in various human cell types (6, 12, 41, 42) . Although the general osteogenic differentiation mechanisms in human and mouse may be similar, differences between the two species in the effect of Notch signaling on this process have been found. It has been reported that immobilized Jagged1 promoted osteogenic differentiation in human MSCs, whereas inhibitory effects were noted for mouse MSCs (41) . The mechanisms underlying these effects require further investigation.
The present study has investigated the influence of Notch signaling on mGF-iPS cell osteogenic differentiation. Our results suggest that Notch signaling participates in the osteogenic differentiation of these cells. The mRNA levels of osteogenic marker genes in these cells were increased upon stimulation with immobilized Jagged1 and decreased when treated with DAPT. However, the effect of altering Notch signaling on mGF-iPS cell osteogenic differentiation was not robust, suggesting that other signaling pathways may be involved in this process.
